Skip to main content

Center Laboratories, Inc.'s Form 4 filing

Windtree Therapeutics Inc (WINT) · filed Jan 10, 2022

Accession no.
0001213900-22-001391
Filed
Jan 10, 2022
Trade date
May 20, 2020-Dec 30, 2021
Filing delay
600 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market purchases total $2.38M. It was filed 600 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Center Laboratories, Inc.CIK 000177042310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 20, 2020Common StockJOtherDisposed−3,551,750$0.00$01,183,916IndirectDuplicate filing
May 20, 2020Common StockPPurchaseAcquired+55,172$7.25+$399,9971,239,088IndirectDuplicate filing
Dec 30, 2021Common StockPPurchaseAcquired+1,239,088$1.60+$1,982,540.81,239,088Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 24, 2020Common StockJOtherDisposed−384,824$0.00$00IndirectDuplicate filing
May 20, 2020Common StockJOtherDisposed−249,004$0.00$0249,004IndirectDuplicate filing
May 20, 2020Common StockPPurchaseAcquired+55,172$0.00$055,172IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)